Company Filing History:
Years Active: 2008
Title: Innovations in Antituberculosis Compounds by Prasit Palittapongarnpim
Introduction
Prasit Palittapongarnpim is an accomplished inventor based in Bangkok, Thailand. He has made significant contributions to the field of biotechnology, particularly in the development of antituberculosis compounds. His work focuses on the isolation and application of novel alkaloids that show promise in treating tuberculosis.
Latest Patents
Prasit holds a patent for his discovery of three new alkaloids, known as Hirsutellones A, B, and C. These compounds are produced in cultures of specific fungus strains, including BCC 2594 and BCC 7579. The Hirsutellones have demonstrated potent growth inhibitory activity against the H37Ra strain of tuberculosis, with a minimum inhibitory concentration (MIC) value of 0.78 µg/ml. Importantly, these compounds exhibit weak or no cytotoxicity to mammalian cells, indicating their potential as safe therapeutic agents. The patent also describes methods for isolating the Hirsutellones, which could facilitate further research and development.
Career Highlights
Prasit is affiliated with the National Center for Genetic Engineering & Biotechnology, which is part of the National Science & Technology Development Agency. His role at this prestigious institution allows him to engage in cutting-edge research and contribute to advancements in biotechnology.
Collaborations
Prasit has collaborated with notable colleagues, including Masahiko Isaka and Nigel Leslie Hywel-Jones. These partnerships enhance the research environment and foster innovation in the field of genetic engineering and biotechnology.
Conclusion
Prasit Palittapongarnpim's work in developing antituberculosis compounds represents a significant advancement in the fight against this disease. His innovative research and collaborations position him as a key figure in the biotechnology sector.